GlassScriptPhysician profile
Andrew Habib
NPI 1609304393
$1,844.02
in general payments reported to CMS, 2019-2025
14 companies · $878 in 2025
The $878 reported for 2025 was more than what 84% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $14.96 · 2022: $133 · 2023: $88.77 · 2024: $730 · 2025: $878.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,687 · Education: $9.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,687.40 |
| Education | $9.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,006.58 | 2022-2025 | Farxiga, Airsupra, Breztri |
| Lilly USA, LLC | $239.54 | 2022-2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $178.53 | 2022-2025 | Ozempic, Wegovy, Rybelsus |
| Amgen INC. | $94.31 | 2024-2025 | Repatha, Otezla, Repatha |
| Exact Sciences Corporation | $68.30 | 2024-2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $57.93 | 2022-2025 | Trelegy Ellipta |
| Kowa Pharmaceuticals America, INC. | $46.10 | 2025 | Zoryve |
| Novartis Pharmaceuticals Corporation | $28.50 | 2025 | |
| Sanofi Pasteur INC. | $28.17 | 2020-2023 | |
| Medtronic, INC. | $27.91 | 2024 | Vanta Adaptivestim |
| Abbott Laboratories | $21.73 | 2024 | Freestyle Libre 3 |
| Astellas Pharma US INC | $18.22 | 2024 | Veozah |
| Bavarian Nordic A/S | $14.39 | 2025 | Vivotif |
| Otsuka America Pharmaceutical, INC. | $13.81 | 2025 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Habib listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.